The Drugs Controller General of India has approved of the commercial launch of 'Feluda', the Tata CRISPR Covid-19 test
 "Covid updates: Guidelines for schools, India's first low-cost test & more")
Listen to This Article
After recording more than 90,000 Covid-19 cases consecutively for five days, on Sunday, India witnessed around 87,000 new cases.
The Drugs Controller General of India has approved of the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test.
Tune in to the podcast for more
Tune in to the podcast for more
More From This Section
First Published: Sep 21 2020 | 1:12 PM IST